All the Active Ingredient Drugs
Phosphodiesterase-5 Enzyme Inhibitor. Tadalafil 2.5, 5, 10, 20 mg. F.C. TABS: 4 x 10 mg; 4, 8 x 20 mg.
On-demand: 10 mg or 20 mg,
depend. response, 30 mins. - 12 hrs
bef. sexual activity. Effic. may persist
for up to 36 hrs. Max: 1 dose dly, but
dly use not recommend. Childr. under
18 yrs: not recommend.
Tmt. erect. dysfunct. in men.
F.C. TABS: 28 x 2.5 mg, 5 mg. Once /d:
For men who anticipate freq. use (min.
2 x wkly): 2.5 mg/5 mg 1 x dly, depend.
on individ. tolerabil. Reassess period.
Tmt. erect. dysfunct. in men.
5 mg only: Tmt. erect. dysfunct. in men. Tmt of the signs, symptoms of BPH. Tmt of ED and the signs and symptoms of BPH (ED/BPH).
C/I:Hypersens./ concom. use of of organic nitrate/
Pts. with cardiac dis. for whom sexual activity is inadvisable/
pts. with MI within the last 90 days/
pts.with unstable angina or angina occurring during sexual intercourse/
pts. with NYHA Class 2 or greater HF in the last 6 months/
pts.with uncontrolled arrhythmias, hypotension (<90/50 mm Hg), or uncontrolled hypertension/pts. with a stroke within the last 6 months/
pts. who have loss of vision in one eye because of non-arteritic anterior
ischemic optic neuropathy (NAION), regardless of whether this episode was in connection or not with previous PDE5 inhib. exposure/ co-admin. of PDE5 inhib., incl. tadalafil, with guanylate cyclase stimulators, such as riociguat.
PDE5 Inhibitor. Tadalafil 20 mg. TABS.: 56. 1 tab.×1/d.
Indic. adults for the tmt. of pulmon. arterial hypertens. classified as WHO funct. class II and III, to improve exercise capacity. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH related to collagen vascular dis.
C/I: Concom. use with nitrates. History or presence of loss of vision as a result of NAION - non-arteritic anterior ischemic optic neuropathy. MI in the last 3 mnths. Hypotens. Concom. use with riociguat.
Phosphodiesterase-5 Enzyme Inhibitor. Tadalafil 20 mg. TABS.: 20mg × 1, 4, 8.
1/2 to 1 tab., at least 30 min. prior to sexual contact.
Not more than 1 tab./ d.
May be taken at any time during the
day. The effect may last up to 36 hrs.
Not for dly. use.
Tmt. of erectile dysfunct. in men.
C/I: Hypersens.
Pts. under any form of organic nitrate ther.
Men with cardiac. dis. to whom sexual. activ. is not advisable.
Pts. with MI within the last 90 d.
Pts. with unstab. angina.or angina occur. during sex. intercourse.
Pts. with NYHA Class 2 or greater heart fail. in the last 6 mnths.
Pts. with uncontroll. arrhythm., hypotens.(<90/50 mmHg), or uncontrol. hypertens.
Pts. with a stroke within the last 6 mnths.
Pts. with loss of vision in one eye due to non-arteritic anterior ischemic optic neuropath. (NAION), regardless of whether this episode was in connect.or not with previous PDE5 inhib.expos.
Co-admin.of PDE5 inhib.
PDE5 Inhibitor. Tadalafil 5, 10, 20 mg. TABS. : 28×5mg, 4×10mg, 4, 8×20mg. 10, 20mg tabs.: 1 tab. ×d. at least 30 min. before sexual contact. not recomm. for permanent dly. use. 5mg tabs.1 tab×/d, at same time each day. See lit.
Tablets of 5, 10, 20mg -Tmt . of erectile dysfunc. in men, for obtaining and maintain. an erection. In addition, tablet of 5mg: Tmt. of BPH symptoms. For tmt. of men suffer. from an erectile dysfunc.and BPH sympt.
C/I: Hypersens. Concom. use with nitrates for agina p. MI within the last 90 d, severe heart dis. Hypotens., uncontrol. hypertens. Stroke within the last 6 mnths. History/presence of loss of vision as a result of a NAION – ischemic optic neuropathy. Concom. use with riociguat.
